Study S000876

A Pilot Study to Determine the Effects of a Single Dose of Exenatide (Byetta ®) on the Acute Metabolic Responses to a Mixed Meal or Intravenous Glucose Tolerance Test in Patients With Type 1 Diabetes

ClinicalTrials.gov record

Registration

Registration: NCT01855490
Study type: INTERVENTIONAL
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 17
Start: 2012-01
Primary completion: 2013-07
Lead sponsor: Yale University
Conditions: Type 1 Diabetes
Interventions: DRUG:Exenatide
Results posted: FALSE

Registered primary outcomes

Effect of exenatide on metabolic responses to an oral (as a mixed meal) or intravenous glucose challenge in subjects with established T1D with or without residual insulin production. [Each patients is estimated to finish the study within 4-6 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.